Kiora Pharmaceuticals (KPRX) Change in Cash (2014 - 2026)
Kiora Pharmaceuticals' (KPRX) quarterly Change in Cash came in at $2.3 million in Q1 2026, up 10718.17% YoY from N/an in Q1 2025, and down 29.14% on a QoQ basis from $3.2 million in Q4 2025.
Kiora Pharmaceuticals (KPRX) Change in Cash (2014 - 2026) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has 13 years of Change in Cash data on file, last reported at $2.3 million in Q1 2026.
- Quarterly Change in Cash rose 10718.17% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.2 million (up 126.12% YoY) and the FY2025 annual result came in at $4.9 million, up 266.73% from the prior year.
- Change in Cash slipped to $2.3 million in Q1 2026, from $3.2 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $28.8 million in Q1 2024 to a low of -$24.7 million in Q2 2024.
- A 5-year average of $180021.0 and a median of -$938034.0 in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2024 — Change in Cash sank 645.81% — and 2026, when it surged 10718.17%.
- Tracing KPRX's Change in Cash over 5 years: stood at $1.2 million in 2022, then plunged by 353.24% to -$2.9 million in 2023, then surged by 37.36% to -$1.8 million in 2024, then soared by 272.76% to $3.2 million in 2025, then dropped by 29.14% to $2.3 million in 2026.
- The last three Change in Cash figures came in at $2.3 million (Q1 2026), $3.2 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Kiora Pharmaceuticals | 15.64 Mn | 15.64 Mn | - | -3.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.88 Mn |
| Mar 31, 2026 | 2.26 Mn |
| Dec 31, 2025 | 3.19 Mn |
| Sep 30, 2025 | 4.48 Mn |
| Jun 30, 2025 | -2.74 Mn |
| Mar 31, 2025 | -21,274.00 |
| Dec 31, 2024 | -1.85 Mn |
| Sep 30, 2024 | -938,034.00 |
| Jun 30, 2024 | -24.70 Mn |
| Mar 31, 2024 | 28.82 Mn |
| Dec 31, 2023 | -2.95 Mn |
| Sep 30, 2023 | -2.55 Mn |
| Jun 30, 2023 | 4.53 Mn |
| Mar 31, 2023 | -2.58 Mn |
| Dec 31, 2022 | 1.16 Mn |
| Sep 30, 2022 | 2.37 Mn |
| Jun 30, 2022 | -2.64 Mn |
| Mar 31, 2022 | -2.79 Mn |
| Dec 31, 2021 | -3.25 Mn |
| Sep 30, 2021 | 7.44 Mn |